Judit Pallares Quixal
Degree: PhD
jpallares.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/A-6635-2010
Groups
Publications
-
Navarro-Masip, E; Petit, NM; Salinas-Roca, B; Herrerías, F; VILARDELL, F; de la Fuente, MC; Pallares, J; Santamaría, M; Zorzano-Martínez, M; Sánchez, E; Matías-Guiu, X; López-Cano, C; Soler, AG; León-Mengíbar, J; Bueno, M; Lecube, A
Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver®) Diagnoses
Obesity Facts 17 473-482. .
-
León-Mengibar, J; Sánchez, E; Herrerías, F; de la Fuente, MC; Santamaría, M; Valdivielso, JM; Bermúdez-López, M; Castro, E; Pallarés, J; Matias-Guiu, X; VILARDELL, F; Caixàs, A; Bueno, M; Marti, R; Lecube, A
Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum
Frontiers in Endocrinology 15 1366015-1366015. .
-
Pallarès J; Torreguitart N; Arqué G; Portero-Otin M; Purroy F
Human atheromatous plaques expressed sensing adaptor STING, a potential role in vascular inflammation pathogenesis.
THROMBOSIS AND HAEMOSTASIS 122 1621-1624. .
-
Nicolas-Sanchez, FJ; Arostegui-Gorospe, JI; Pallares-Quixal, J; Nicolas-Sarrat, FJ; Sarrat-Nuevo, RM; Bou, RMN; Melgarejo-Moreno, PJ
p.RQ92 mutation associated with amyloidosis
REUMATOLOGIA CLINICA 17 46-48. .
-
Lecube, A; Valladares, S; Lopez-Cano, C; Gutierrez, L; Ciudin, A; Fort, JM; Reñé JM; Matias-Guiu, X; de Torres, I; Bueno, M; Pallares, J; Baena, JA
The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori
PLOS ONE 11 -. .
-
Fuste, NP; Castelblanco, E; Felip, I; Santacana, M; Fernandez-Hernandez, R; Gatius, S; Pedraza, N; Pallares, J; Cemeli, T; Valls, J; Tarres, M; Ferrezuelo, F; Dolcet, X; Matias-Guiu, X; Gari, E
Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer
Oncotarget 7 26979-26991. .
-
Bergadà L; Pallares J; Arcidiacono MV; Cardus A; Santacana M; Valls J; Cao G; Fernàndez E; Dolcet X; Dusso AS; Matias-Guiu X
Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma
LABORATORY INVESTIGATION 94 608-622. .
-
Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X
Optimal protocol for PTEN immunostaining; role of analytical and preanalyticat variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues
HUMAN PATHOLOGY 45 522-532. .
-
Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X
An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias
DISEASE MODELS & MECHANISMS 6 710-720. .
-
Azueta, Ainara; Maiques, Oscar; Velasco, Ana; Santacana, Maria; Pallares, Judith; Novell, Anna; Llombart-Cussac, Antonio; Gonzalez-Tallada, Xavier; Mozos, Ana; Prat, Jaime; Pillai, Raji; Mata, Manuel; Matias-Guiu, Xavier
Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin
HUMAN PATHOLOGY 44 20-28. .
-
Pallares, J; Bergada, L; Santacana, M; Dolcet, X; Valls, J; Dusso, A; Matias-Guiu, X
Downregulation of CYP27A1 Expression and Activity in Human Endometrial Carcinoma Implicates an Abnormal Bioactivation of Vitamin D in Advanced Endometrial Carcinogenesis
Modern Pathology 25 291-291. .
-
Gatius, Sonia; Velasco, Ana; Azueta, Ainara; Santacana, Maria; Pallares, Judit; Valls, Joan; Dolcet, Xavier; Prat, Jaime; Matias-Guiu, Xavier
FGFR2 alterations in endometrial carcinoma.
Modern Pathology 24 1500-1510. .
Projects
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
- Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
- CARCINOMA DE ENDOMETRIO. VALORACION DELECCIONES Y AMPLIFICACIONES DE REGIONES CROMOSOMICAS MEDIANTE ARRAYS DE CGH
- Alteraciones de la modulación de la vía RAS-MAPK y PI-3K en el cáncer de endometrio RASSF1A, NORE1A, Sprouty y PI3CA